XRF SCIENTIFIC LIMITED (XRF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

XRF

XRF - XRF SCIENTIFIC LIMITED

FNArena Sector : Mining Sector Contracting
Year End: June
GICS Industry Group : Capital Goods
Debt/EBITDA: 0.17
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$2.09

31 Oct
2025

-0.070

OPEN

$2.12

-3.24%

HIGH

$2.14

257,701

LOW

$2.09

OTHER COMPANIES IN THE SAME SECTOR
ALQ . ANG . ARI . C79 . CDA . DNL . DOW . EHL . GNG . IMD . IPG . LBL . LYL . MAD . MAH . MIN . MLG . MND . MSV . MYE . NWH . ORI . PRN . RAN . RCR . RUL . SGH . SRG . SXE .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

Last ex-div: 01/10 - ex-div 1.4c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx7.4
DPS All xxxxxxxxxxxxxxx4.5
Sales/Revenue xxxxxxxxxxxxxxx59.2 M
Book Value Per Share xxxxxxxxxxxxxxx42.8
Net Operating Cash Flow xxxxxxxxxxxxxxx10.1 M
Net Profit Margin xxxxxxxxxxxxxxx17.54 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx18.05 %
Return on Invested Capital xxxxxxxxxxxxxxx17.58 %
Return on Assets xxxxxxxxxxxxxxx14.73 %
Return on Equity xxxxxxxxxxxxxxx18.05 %
Return on Total Capital xxxxxxxxxxxxxxx25.58 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx4.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx2 M
Total Debt xxxxxxxxxxxxxxx3 M
Goodwill - Gross xxxxxxxxxxxxxxx16 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx12 M
Price To Book Value xxxxxxxxxxxxxxx4.30

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx2.2 M
Capex % of Sales xxxxxxxxxxxxxxx3.64 %
Cost of Goods Sold xxxxxxxxxxxxxxx32 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx12 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

29/10/2025

1

Buy

$2.35

12.44%

Canaccord Genuity highlights XRF Scientific’s 1Q26 result showed strong revenue growth up 17% y/y to $15.3m and PBT of $3.4m up 6% y/y, though margins softened due to seasonality and a shift away from higher-margin Consumables.

The broker highlights higher platinum prices boosted revenue but reduced percentage margins, while lower Consumables sales are expected to normalise in 2Q26.

Capital Equipment sales and outlook remain positive, with the upcoming Orbis product cycle in North America expected to support demand.

The analyst's forecasts were marginally adjusted, with revenue lifted 1.7% for FY26 and net profit estimate unchanged at $11.7m.

No change to Buy rating. Target rises to $2.35 from $2.26.

FORECAST
Canaccord Genuity forecasts a full year FY26 dividend of 5.00 cents and EPS of 8.30 cents.
Canaccord Genuity forecasts a full year FY27 dividend of 5.60 cents and EPS of 9.30 cents.

XRF STOCK CHART